Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study

NCT03183895 is registered in ClinicalTrials.gov with Ancora Heart, Inc. as lead sponsor.

NCT NCT03183895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03183895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Lead sponsor
Ancora Heart, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 15, 2019
Completion date
December 31, 2027
Enrollment
132 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathies, heart failure